[Team Name] Monthly Technical Report [Safe Genes Program] Project PoP: [Start and End Dates for the project] Reporting Period: [dates report covers] Briefing Prepared for Renee Wegrzyn Distribution Statement

Distribution Statement Project Overview A few bullets or figures that serve as a reminder of the key goals of the project, and why it’s “DARPA hard”. Distribution Statement

Accomplishments and Challenges to Date Accomplishments (cumulative): List 1-5 bullets that cover your technical accomplishments to date – these are the big wins and key proofs-of-concept. Be sure to include any successful transitions Summarize all of the publications, patents, spin-off companies, etc that have resulted from this work (you can use a separate slide) Challenges: please include 1-3 condensed bullets discussing the technical challenges you faced, and if/how you overcame them. Primary focus is to summarize your accomplishments and challenges since the start of the effort. Distribution Statement

Technical Progress - Executive Overview Technical progress update: List 1-5 bullets that cover your progress, to include but not limited to, technical accomplishments, technical status, notable events/publications, deliverables achieved..; Set up the story you are about to tell in the supporting data slides with regard to your progress or problems. Primary focus is to summarize your technical progress during the last reporting period and identify potential timeline issues. Distribution Statement

Milestones and Task Status Overview Insert table of objectives, quantitative metrics, and milestones as listed in the original or approved contract modifications. List the current status for (percentage of completion and date to be completed)-(declare whether ahead of schedule, as scheduled, or behind schedule). For all tasks active or scheduled to be active this past quarter, provide the information indicated in the example table below: [Team Name] Active Task Status – Past Month Date: SOW Task # Contract Start Due Date Actual Start Actual Finish Status (%) Exit Criteria (Milestones and Deliverables) Issues and Status 1.0 Task description     1.1 Subtask description 1/1/2014 3/31/2014 100% 1.2 2/28/2014 5/31/2014 1.3 6/30/2014 1.4 11/1/2014 50% 1.5 12/15/2014 25% 2.0 2.1 MM/DD/YYYY 2.2 2.3 2.4 2.5 Distribution Statement

[Task Identifier and Title (e.g. 1.3 – Biofidelic Modeling)] For tasks with key progress during this reporting period, please include a slide with supporting figures/images/videos: figure/image/video [Brief text description] Distribution Statement

Exit Criteria (Milestones and Deliverables) Upcoming Tasks Anticipated work for next reporting period: please include 1-3 condensed bullets discussing your planned efforts for the *next* reporting period For ADDITIONAL tasks that will be active or are scheduled to be active NEXT reporting period, provide the information indicated in the example table below: [Team Name] New Tasks in Coming Month Date: SOW Task # Contract Start Due Date Actual Start Predicted Finish Status (%) Exit Criteria (Milestones and Deliverables) Reason for Delay 1.0 Task description     1.6 Subtask description 1/1/2014 3/31/2014 100%  N/A 1.7 2/28/2014 5/31/2014 1.8 6/30/2014 1.9 11/1/2014 50%  IRB resubmission 2.0 2.6 MM/DD/YYYY 3.0 Task description 3.6 3.7 Distribution Statement

Public Affairs and Public Engagement Publications Drafts In Progress – Attach manuscripts in pre-print Published Meetings Upcoming Dates and Audience – Attach slides Meeting Outcomes and Follow up Items for Public Release Attach drafts of press releases, slides, manuscripts, articles, etc at least one month in advance of date needed for distribution Distribution Statement

Additional slides to consider as needed… Data sharing and analysis Scope of the files and opportunities to support and grow data storage and sharing Platforms used Data files uploaded with parameters, context Engagement (if not a task reported above) LEEDR Panel – one-on-one or issues for upcoming quarterly calls Communities Regulatory – Include Organizations and POCs Other Compliance Animal protocols Biological Safety Confirm not HSR Other IRB issues or other biosafety approvals/data calls, i.e., for BWC, etc.) Other attachments for DARPA PM/COR/CO awareness or comment Distribution Statement

Additional Items for Discussion Administrative Issues Questions or Concerns not addressed in previous slides Major challenges Distribution Statement

Distribution Statement Detailed spend plan Financials: [Indicate original spend plan in contract, percent of funds expended, balance relative to spend plan, funding issues, cost risks] [Add financial information to the embedded chart—data included now is just to be used as an example] [Provide a short explanation of any significant deviation from the originally proposed spend plan] Distribution Statement

Spend Plan Deviation Details/Mitigation plan Distribution Statement